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Abstract
When a biopsy is taken of a suspicious pigmented skin lesion, histological examination is expected
to establish the definitive diagnosis. This study evaluated the inter-observer variation of 20
pathologists in the histological diagnosis of a randomly selected set of suspicious pigmented
skin lesions (PSLs), by comparing their diagnoses to a reference diagnosis. Overall sensitivity
for melanoma was 87%, ranging from 55% to 100% between the observers. Sensitivity was
significantly lower for thin (Breslow thickness <1 mm) than for thick melanomas (83% versus
97%, p=0.005). Overall melanoma specificity was 94%, ranging from 83% to 100% between
observers. Dysplastic naevus was the most important source of false-positive diagnoses, mainly in
situ melanomas. Positive and negative predictive values in the given test set were 75% and 97%,
respectively. In the case of melanoma, there was quite some variation in measured Breslow
thickness. This would have led to a different therapeutic approach in 12% of the readings. Some
of the variation seemed to be due to a different interpretation of the presence of a co-existent
naevus. In 9% (3/35) of the readings, participants did not agree on the presence of ulceration.
These results reflect a tendency to overdiagnose mainly thin melanomas in general histopatho-
logical practice. They also demonstrate variation in the assessment of major prognostic factors of
melanoma. Copyright # 2002 John Wiley & Sons, Ltd.
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Introduction
Increased awareness of melanoma among health pro-
fessionals and the public has led to an increase in the
number of biopsies of pigmented skin lesions (PSLs)
over time [1,2]. Histological examination is used to
predict the biological behaviour of the PSL and to
attempt to reach an exact diagnosis. In the case of
melanoma, the pathologist evaluates some tumour
characteristics which can affect prognosis and patient
management, such as the Breslow thickness and the
presence or absence of ulceration [3].
Several studies have shown that pathologists do not
always agree on the diagnosis and biological behaviour
of PSLs [4–11]. The assessment of Breslow thickness
and ulceration in melanoma, two major prognostic
factors in local disease, has been shown to have good
reproducibility [8,12–17], but inter-observer agreement
for other tumour characteristics such as Clark’s level,
histological subtype, and the presence or absence of an
associated naevus tends to be poor or intermediate at
best [8,12–16]. Most of these studies were performed
among expert pathologists who were presented a
highly selected set of slides. Moreover, artificial
conditions which can induce inter-observer discor-
dance, such as serial sections or lack of any clinical
information, were not always taken into account [18].
In the present study, a randomly selected set of
biopsies of clinically suspicious PSLs was circulated
to a group of general pathologists within a routine
practice setting. All participants were sent the original
slides and provided with the original clinical informa-
tion. For each slide, information on slide quality and
additional investigations that would be performed in
routine practice was acquired.
Materials and methods
Histological slides were selected from the Dermato-
pathology Department, University Hospital Ghent. All
diagnostic slides of PSLs removed because of one or
more clinically suspicious features (asymmetry, border
irregularity, colour variegation, size of more than
6 mm, elevation, increase in size or darkening of a
mole) and received in January, April, July, and
October 1996 were selected (n=66). Twenty patho-
logists volunteered to participate. Most of them were
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recruited during a medical education session on breast
pathology.
Slides were sent to the participants in sets of 6–7.
The pathologist was asked to complete a standard
protocol (Table 1) for each slide and to return it with
the slides within 2 weeks. The protocol was approved
by all participants before the start of the study. Each
protocol was marked with a code specific for the
pathologist. The top of the protocol mentioned the
slide number and the clinical information provided on
the original pathology request form. Pathologists were
asked whether each slide was sufficient to establish a
definitive diagnosis. They were then asked to make a
diagnosis, selecting one of the proposed diagnostic
classes. No discussion on the diagnostic criteria was
organized prior to the study, as the purpose was to
check variability in a normal routine practice setting.
In cases of in situ or invasive melanoma, participants
were asked to evaluate some additional characteristics.
Criteria for classifying histological subtype and Clark’s
level, and for measuring Breslow thickness, were
summarized on the protocol.
One set of six slides was sent twice to each
participant to evaluate intra-observer variability. Not
all pathologists completed all sets of slides (90% of all
expected evaluations); the most frequent reason given
was lack of time.
Sensitivity, specificity, and predictive value of a
diagnosis were calculated by comparison with a
reference diagnosis [19]: this was the initial diagnosis
made at the dermatopathology department, if more
than 80% of all pathologists agreed, or the diagnosis
made by a panel of expert (dermato)pathologists (EG,
EH, JMN or DR, GP, JMN). In addition, the panel
reviewed all slides where an original diagnosis of
melanoma was made. A total of 50 slides were
reviewed by the panel. In two slides, the panel did not
agree on whether the lesion was malignant or benign
and these slides were omitted from the analysis. In
another two slides, there was disagreement on the exact
diagnostic class of the lesion (common versus atypical
naevus and congenital versus common naevus). The
other slides consisted of 11 melanomas (nine invasive,
one in situ, one metastasis), 46 naevi (32 common,
seven atypical, three blue, two congenital, two Reed’s),
and five non-melanocytic lesions.
The chi-squared test was used to test for difference
of proportions [20]. The Spearman rank correlation
coefficient was used to test a linear correlation between
two continuous variables [21]. The sign test was used
to test for a trend in a series of categorical values [22].
Results
The mean number of practising years among partici-
pating pathologists was 14 years (range 0.5–34 years).
The load of PSLs in routine practice ranged from 4 to
50 per week, with a mean of 16.
Overall, 91% of all slides were found convenient for
Table 1. Standard protocol
Pathologist’s code XXX
Slide number – clinical information
$ Slide reading suitability
According to your appreciation, can this slide be evaluated adequately? Yes/no
In routine practice, would you perform additional immunohistochemical examinations? Yes/no
In routine practice, would you ask for a colleague’s opinion or would you consult a textbook? Yes/no
Did you ask for a colleague’s opinion or did you consult a textbook? Yes/no
$ Diagnosis
$ melanoma: in situ/invasive/no primary tumour
$ common naevus: junctional/compound/intradermal




$ pigmented spindle cell naevus (Reed)
$ other: ...
$ In cases of diagnosis of primary melanoma
$ complete resection: Yes/no
$ histological subtype: – melanoma in situ: – radial growth phase with pagetoid pattern
– radial growth phase with lentiginous pattern
– radial growth phase, cannot be classified
– lentigo maligna melanoma/acral-lentiginous melanoma
– superficial spreading melanoma
– nodular melanoma
– not classifiable
$ presence of ulceration: yes/no
$ Breslow thickness: %.%%mm
$ Clark level: I/II/III/IV/V
$ associated naevus: yes/no
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adequate evaluation by the participants (range
77–97%). Reported slide reading suitability was
lower in melanoma than non-melanoma lesions [86%
versus 92% (p=0.015)]. Reasons for poor slide read-
ing suitability were remarks about slide preparation
(45%), such as staining and thickness of the sec-
tions, and insufficient material to establish a definitive
diagnosis (39%). Some other reasons were insufficient
clinical information (7%), the need for additional
investigations such as immunohistochemistry (5%),
and damage to the slide (4%). The panel considered
44 of the 48 slides (92%) adequate for evaluation.
In 46% of the melanoma lesions (range from 0 to
100% among observers) and 12% of the non-melanoma
lesions (range from 0 to 58% among observers), the
participants would have performed immunohistochem-
istry in routine practice. Sixty-five per cent of the
additional immunohistochemical examinations would
have consisted of HMB45 and/or S100. Common
leukocyte antigen (CLA), trichrome or vimentin detec-
tion would have been performed in another 7% of the
slide readings. The panel would have performed
additional immunohistochemistry in five of the 48
slides (10%), with S100 and/or HMB45 in 80%.
In 49% of the melanoma lesions [range from 9%
(1/11) to 100% (11/11)] and in 24% of the non-
melanoma lesions [range from 7% (4/54) to 73% (37/
51)], participants would have discussed the slide with a
colleague or would have consulted a book in routine
practice. In 15% of the melanoma evaluations and in
9% of the non-melanoma lesions, they effectively did
so. The frequency with which they would seek advice
was negatively correlated with their experience
(number of practice years multiplied by the load of
PSLs seen in everyday practice) in non-melanoma
lesions (r=x0.61, p<0.01). This correlation was not
statistically significant in melanoma lesions (r=x0.40,
p=0.12).
Melanoma sensitivity and specificity
Overall sensitivity for melanoma was 87% (range
55–100%) (Table 2). Sensitivity was higher in thick
melanomas (Breslow thickness >1 mm) than in thin
melanomas [97% versus 83% (p=0.005)]. Other sug-
gested diagnoses were dysplastic naevus (12%, with
11% compound type) and common compound naevus
(5%) in case of thin melanomas, and Spitz (2%) and
dysplastic compound naevus (1%) in case of thick
melanomas.
Overall melanoma specificity was 94% (range
83–100%) (Table 2). False-positive melanoma diag-
noses were made in dysplastic naevi (46%, with 44%
of junction type), blue naevi (30%), common naevi
(14%, with 11% of junctional type), Reed’s naevus
(4%), and in a non-melanocytic lesion (7%) (Table 3).
Most false-positive melanoma diagnoses were in situ
Table 2. Calculated sensitivity, specificity, and positive
and negative predictive values of a melanoma diagnosis.
In the event that not all slides were reviewed by a parti-
cipant, the number of slides for which a protocol was






Pathologist 1 100 96 85 100
2 89 (9) 90 (48) 62 98
3 82 94 75 96
4 90 (10) 96 (52) 82 98
5 55 96 75 91
6 100 92 (52) 73 100
7 91 89 63 98
8 100 96 82 100
9 91 94 (52) 77 98
10 89 (9) 98 89 98
11 82 100 (52) 100 96
12 100 83 55 100
13 71 (7) 96 (46) 71 96
14 67 (3) 100 (22) 100 96
15 90 (10) 96 (52) 82 98
16 91 90 (51) 67 98
17 Missing 100 (5) Missing 100
18 82 98 90 96
19 91 92 (52) 71 98
20 80 (10) 94 73 96
Total 87 94 75 97
Table 3. Diagnostic classification of benign melanocytic lesions: participating pathologists versus reference diagnosis.

























17.6% 3.2% None 29.6% 45.6% None None 4% None None
Congenital naevus
(n=2, 35 evaluations)








2.6% 2.6% None 10.5% 31.6% None None 47.4% 5.3% None
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melanomas (n=29). Nevertheless, eight invasive mela-
nomas with a Breslow thickness ranging from 0.26 to
2.8 mm were diagnosed. Blue naevus caused confusion
with melanoma metastasis (Table 3), especially in one
particular slide.
Leaving out those slides that were considered not
optimal for evaluation did not change sensitivity and
specificity significantly (p>0.05). Excluding those
readings where a second opinion and/or additional
immunohistochemistry would have been asked in nor-
mal routine practice did not affect melanoma sensiti-
vity (p>0.05), while it increased melanoma specificity
from 94% to 98% (p=0.0001).
There was no correlation of melanoma sensitivity
and specificity with years of practice or the routine
load of PSLs (p>0.05). There was a negative correla-
tion between the ability to recognize benign disease
(melanoma specificity) and the frequency with which a
colleague or a textbook would have been consulted in
routine practice (r=x0.52, p<0.001).
In the set of six slides that was sent twice, six
different pathologists switched from melanoma to a
benign PSL, or vice versa, in five different slides. The
second reading tended to be more in agreement with
the reference diagnosis (96% versus 87%; x2=4.39,
p=0.04).
Evaluation of melanoma characteristics
Of the ten primary melanomas (one in situ, nine
invasive), five were classified by the panel as the
superficial spreading type. One was considered lentigo
maligna melanoma and three were judged not classifi-
able. Participants’ agreement with the panel was 55%.
Agreement on the four superficial spreading melano-
mas reached 93%, while agreement for the other
tumours was only 21%.
The panel of experts reported ulceration in two
thick melanomas (Breslow depth of 2.6 and 3.3 mm).
Participants did not agree in three of the 35 readings
(9%). Overall agreement on the presence or absence of
ulceration was 98%.
There was 77% agreement on the evaluation of the
presence or absence of an associated naevus. The
lowest agreement (24%) was found in the two slides
where the panel concluded that an associated naevus
was present.
Agreement on Clark’s level was highest in level II
(81%) and lowest in level III (26%). Agreement for
Clark’s level IV was 65%. The observers’ and panel’s
observation of the level of invasion was concordant in
59% of all evaluations. In 30% of the evaluations, the
level reported by the participants was one level lower
(20%) or higher (10%) than that of the panel. In 11%
of the evaluations, there were two levels of difference
with the panel (all lower). Pathologists tended to
underscore Clark’s level compared with the panel
(p<0.001).
The mean difference of Breslow thickness assessed
by the pathologist and by the panel was x0.09 mm
(SD=0.52), but the extremes ranged from x2.40 mm
to +1.67 mm. The range of differences varied con-
siderably with the observer and with the slide
(Figure 1a and 1b). Variation tended to be higher in
thicker tumours (Figure 1b). Discordant evaluations of
an associated naevus seemed to be at the basis of some
of the observed differences in measured Breslow
thickness (Figures 1a and 1b). For 12% of all evalua-
tions there would have been different patient manage-
ment, based on the Breslow thickness assessed by the
pathologist or by the panel (cut-off at 1 mm depth).
Diagnostic classification of benign lesions
On 53 PSLs that were considered benign, the panel did
not agree on the exact diagnostic class of two. These
two slides were omitted from this analysis.
Overall, there was 70% agreement on the diagnostic
classification of benign melanocytic lesions. The
majority of these lesions were common naevi and the
pathologists had a concordant diagnosis (including
naevoid lentigo) in 78% of all evaluations (Table 3). In
nearly 11%, a diagnosis of dysplastic naevus was made.
In situ melanoma was diagnosed in five different slides
by five different pathologists, and invasive melanoma
was diagnosed in two readings (one Breslow missing
and the other 0.90 mm).
In 45.6% of their evaluations, pathologists agreed
with the reference diagnosis of dysplastic naevus
(Table 3). Four of the seven slides with a reference
diagnosis of dysplastic naevus gave rise to 22 false-
positive diagnoses of in situ melanoma. In addition,
four false-positive diagnoses of invasive melanoma
(Breslow ranging from 0.26 to 0.75 mm) were made
(three different slides, three different pathologists).
All three slides of blue naevi caused problems of
diagnostic classification (Table 3). A diagnosis of
melanoma metastasis was suggested in 16 evaluations.
In 13, this was due to one particular slide where the
PSL had been excised near the scar of a former
melanoma resection. In the latter slide, there was also
one false-positive diagnosis of invasive melanoma,
Breslow 2.8 mm.
Reed’s naevus was recognized in 47.4% of all
evaluations. In about one-third, it was diagnosed
as dysplastic naevus. There was one diagnosis of
melanoma in situ and one of invasive melanoma
(Breslow 0.77 mm).
Three non-melanocytic lesions were diagnosed as
melanocytic by five different pathologists: a dermato-
fibroma was diagnosed as a desmoplastic naevus and
an angioma as a common naevus; an early evolv-
ing seborrhoeic keratosis was diagnosed four times
as melanoma in situ, of which two were classified as
Dubreuilh’s melanosis. One seborrhoeic keratosis was
diagnosed twice as basal cell carcinoma.
In the set of benign melanocytic lesions that was
read twice by the participants (three common naevi,
one dysplastic naevus, and one Reed’s naevus), the
diagnostic class was changed in 23% of the second
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readings. The second reading tended to be more in
agreement with the panel’s diagnosis, although this
was not statistically significant [76% versus 67%,
(p=0.24)].
Discussion
In this study, a randomly selected set of biopsies of
PSLs with one or more clinically suspicious features
was circulated to a group of volunteer general
pathologists with a routine practice. Care was taken
to avoid conditions which could induce inter-observer
variability [18,23].
Overall sensitivity for melanoma was 87%. Sensi-
tivity was significantly lower in thin melanomas
(Breslow<1 mm), where one in six readings resulted
in a diagnosis of naevus (mainly dysplastic and mainly
of the compound type). Inter-observer variation in thin
melanomas, which have shown a considerable increase
in the second half of the 20th century [24], has been
reported [7,8] and the exact malignant potential of
these lesions has been discussed [25]. The concept of
radial growth phase (RGP) melanoma, which was
proposed by Clark et al. in 1984 [26], implies a
progression stage of invasive melanoma incapable of
metastasis [27]. Inter-observer variation for the recog-
nition of RGP versus vertical growth phase (VGP) in
melanoma ranged from fair to good [10,17].
In the present study, melanoma specificity was 94%,
increasing to 98% excluding the readings where
additional advice or immunohistochemistry was not
Figure 1. Difference in measured Breslow thickness between the panel and the participating pathologists. (a) Differences for the
individual pathologists. (b) Differences for the individual slides. Plus signs mark evaluations where there was a discordant opinion on
the presence or absence of an associated naevus between the participating pathologist and the panel
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performed while it would have been in normal routine
practice. The negative correlation between specificity
and the frequency with which a colleague or textbook
would have been consulted in routine practice could
indicate a tendency to overdiagnose melanoma in case
of doubt about the biological behaviour of the lesion.
A tendency to overdiagnose thin melanomas has been
reported [7].
Dysplastic naevi of the junctional type were the
PSLs most often misdiagnosed as melanoma, mainly
melanoma in situ. Cook et al. suggested the use of the
MIN (melanocytic intraepidermal neoplasia) termino-
logy, by analogy with CIN (cervical intraepithelial
neoplasia), because of the difficulty in discriminating
between (severely) dysplastic naevi and in situ/RGP
melanoma [7,10]. However, dysplastic naevi and in situ/
RGP melanoma may have a different clinical signifi-
cance. While the latter are considered progression
stages of malignant disease [26], the clinical significance
of naevi with histological dysplasia is not established
and its prevalence in the normal population has been
estimated from 10% up to 47% [28,29]. In contrast,
clinically atypical naevi are a marker for increased
melanoma susceptibility and are possible precursor
lesions of melanoma [30–33]. There is a poor correla-
tion between clinical atypia and the presence of
histological dysplasia [33]. Studies on the recognition
of naevi with histological dysplasia have shown
divergent results [34]. In this study, less than 50% of
the dysplastic naevi were classified as such. However,
histopathological criteria for diagnosing dysplastic
naevi have been shown to be reproducible [35,36] and
problems seem to lie mainly at the extremes of the
spectrum (dysplastic naevi with severe dysplasia versus
melanoma in situ, dysplastic naevi with mild dysplasia
versus common naevus) [5,35].
Despite the relatively high specificity for melanoma,
there is an important number of false-positive mela-
noma diagnoses, because the majority of the PSLs
presented to the pathologist are benign: in 6% of the
readings of 53 benign PSLs, the pathologist did not
agree with the innocuous nature of the lesion, resulting
in 57 false melanoma diagnoses, consisting mainly of
in situ melanomas and thin invasive melanomas. This
important ‘burden’ of false-positive diagnoses is also
reflected by the positive predictive value in the current
study setting (Table 2): overall, one-quarter of all
melanoma diagnoses were made in benign lesions. On
the other hand, the negative predictive value in the
current test setting was high (97%), indicating that the
risk for a patient having melanoma in the event of a
negative diagnosis is low. It is likely that in general
histology practice the ratio of benign/malignant lesions
is even higher than in this experimental setting (4.8 : 1),
which would further reduce the calculated positive
predictive value of a melanoma diagnosis.
In the set of six slides that was sent twice, the second
reading tended to be more in agreement with the
reference diagnosis, indicating a learning effect
and/or habituation to the specific slide processing
characteristics.
Even among experts, there may be disagreement on
the estimated biological behaviour of PSL [9,11] and
the only certainty about the benign/malignant nature
of a lesion is the eventual outcome for the patient.
Thickness measured according to Breslow is a major
prognostic factor in local disease, on which fur-
ther management is often based [3]. Despite the fact
that this is an objective, reproducible measurement
[8,12–14,16,17], this study indicates that there is still an
important variation in routine practice, with possible
therapeutic implications for the patient. Errors inher-
ent in the measuring instrument may be expected to
produce variations of 0.1–0.5 mm [12,14]. Other varia-
tions may be due to different interpretations of the
deepest invasive tumour cell [12,14]. In this study,
some of the differences in measured Breslow thickness
between the participants and the panel seemed to be
related to a different interpretation of the presence or
absence of a co-existent naevus. Larger variations may
be attributable to errors in the conversion of micro-
metre units into millimetres [12,14]. Finally, although
we presumed that participating pathologists used the
same measuring technique and criteria (described on
the protocol), some may use other techniques in
routine practice [37]. Clark’s level has been reported
to be less reproducible than Breslow thickness
[8,12–14,17]. This is probably inherent in the fact that
it is a categorical variable, forcing the pathologist to
choose one category [12,13]. The lowest agreement has
been observed for Clark level III. This has been
attributed to the difficulty in assessing the interface
between papillary and reticular dermis [12,13].
Ulceration is the second major independent prog-
nostic factor in local disease, which will be incor-
porated in the new pTNM staging system [3]. In
this study, the presence of ulceration was missed in two
melanoma cases by three pathologists. Although
several studies reported good reproducibility of this
characteristic [8,13,16], Heenan et al. reported that
inter-observer congruence was lower than one might
expect. They suggested that this might be related to the
recognition of small foci of ulceration (less than 3 mm
wide), of which the prognostic significance is question-
able [13]. However, the areas of ulceration in this study
were clearly wider, so that discordant observations
probably pertain to inaccuracy of the observer.
In conclusion, the increased presentation of border-
line lesions seems to have complicated the histo-
pathological diagnosis of PSLs. On the one hand, a
proportion of the melanomas removed in an early
phase of tumour progression may not be recognized;
many of these lesions, however, may not display
clinically aggressive behaviour [27,38]. On the other
hand, there may also be an ongoing overdiagnosis of
(especially thin) melanomas, which may be further
stimulated by increased awareness and the pressure not
to miss such an important diagnosis as melanoma.
It is difficult to estimate the extent, and hence the
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cost, both at the community and at the individual level,
of melanoma under- and over-diagnosis in general
histopathological practice. In this study, 13% of the
readings were reclassified from benign to malignant
and 2–6% were reclassified in the other direction. Since
melanoma is a relatively infrequent cancer in most
European countries, it is likely that patients receiving
an inappropriate diagnosis of melanoma outnumber
those in whom melanoma is missed. It also implies that
the histological diagnosis of a benign lesion is probably
more reliable than that of a malignant lesion (with a
high negative predictive value and a lower positive
predictive value).
These phenomena are inherent in the fact that
histological diagnosis is based on the interpretation of
a visual image, which is subjective to some extent
[9,39]. New diagnostic techniques for detecting genetic
or functional changes specific for the malignant
transformation of melanocytes would bring significant
progress in the classification of borderline lesions.
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